Trending...
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
DETROIT, Mich. and AWKA, Nigeria, June 5, 2024 ~ Detroit-based global health technology company, Functional Fluidics, has proudly announced the opening of its new clinical research center and laboratory in Awka, Nigeria. The state-of-the-art facility will serve as the company's initial entry into Sub-Saharan Africa, supporting the growing need for clinical trial infrastructure.
For nearly a decade, Functional Fluidics has been dedicated to accelerating the development of life-changing therapies and bridging the gap between clinical research and patient care. During this time, there has been a significant investment in red blood cell modifying therapies by pharmaceutical companies, with a focus on sickle cell disease. In fact, between July 2017 and December 2023, the FDA approved three pharmaceutical and two gene editing therapies for sickle cell disease. Currently, there are approximately 20 pharmaceutical companies developing a pipeline of red blood cell therapies with an initial focus on sickle cell disease. As a result, these companies have expanded their clinical trials outside of the U.S. and Europe into Sub-Saharan Africa.
More on Michimich.com
The decision to open a facility in Nigeria was driven by the fact that Sub-Saharan Africa is considered the global epicenter of sickle cell disease (SCD). According to the World Health Organization, nearly 70% of the global SCD population lives in Africa. Nigeria bears the greatest burden with an estimated 4-6 million people living with SCD and one in every four individuals carrying the sickle cell trait.
Functional Fluidics Nigeria will play a crucial role in establishing a global standard for defining red blood cell health and generating high-quality data for research and clinical trials. This will ultimately ensure that innovative therapies are accessible to those who need them most.
Founder and CEO of Functional Fluidics, Dr. Patrick Hines expressed his excitement about this milestone for the company stating, "Our goal of facilitating the development of new therapies and improving the lives of individuals living with sickle cell disease in Nigeria and globally has finally become a reality. We are grateful to our dedicated team and stakeholders for their ongoing commitment and support for patients."
More on Michimich.com
Dr. Nnamdi Okeke, Vice President and Head of Global and Medical Affairs, has been instrumental in managing the buildout of the facility in Nigeria over the past year. He emphasized the significance of this new research center, saying, "Our new clinical research facility brings hope to the millions of individuals with sickle cell disease, the warriors who have never been educated on this disease, and the many families who have lost their loved ones. This research center allows them to actively participate in the development of new sickle cell therapies. This is just the beginning; we have a tremendous amount of work remaining."
The opening of Functional Fluidics' new clinical research center and laboratory in Nigeria marks an important step towards improving access to life-changing therapies for those living with sickle cell disease in Sub-Saharan Africa. With their dedication to bridging the gap between clinical research and patient care, Functional Fluidics is making a significant impact on global health.
For nearly a decade, Functional Fluidics has been dedicated to accelerating the development of life-changing therapies and bridging the gap between clinical research and patient care. During this time, there has been a significant investment in red blood cell modifying therapies by pharmaceutical companies, with a focus on sickle cell disease. In fact, between July 2017 and December 2023, the FDA approved three pharmaceutical and two gene editing therapies for sickle cell disease. Currently, there are approximately 20 pharmaceutical companies developing a pipeline of red blood cell therapies with an initial focus on sickle cell disease. As a result, these companies have expanded their clinical trials outside of the U.S. and Europe into Sub-Saharan Africa.
More on Michimich.com
- C & C Heating & Air Conditioning provides pre-vacation home checklist
- Spanglish Entertainment Announces Inaugural Spanglish Party Cruise: A Celebration of Music and Culture
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations
The decision to open a facility in Nigeria was driven by the fact that Sub-Saharan Africa is considered the global epicenter of sickle cell disease (SCD). According to the World Health Organization, nearly 70% of the global SCD population lives in Africa. Nigeria bears the greatest burden with an estimated 4-6 million people living with SCD and one in every four individuals carrying the sickle cell trait.
Functional Fluidics Nigeria will play a crucial role in establishing a global standard for defining red blood cell health and generating high-quality data for research and clinical trials. This will ultimately ensure that innovative therapies are accessible to those who need them most.
Founder and CEO of Functional Fluidics, Dr. Patrick Hines expressed his excitement about this milestone for the company stating, "Our goal of facilitating the development of new therapies and improving the lives of individuals living with sickle cell disease in Nigeria and globally has finally become a reality. We are grateful to our dedicated team and stakeholders for their ongoing commitment and support for patients."
More on Michimich.com
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- Colbert Packaging Announces WBENC Recognition
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
Dr. Nnamdi Okeke, Vice President and Head of Global and Medical Affairs, has been instrumental in managing the buildout of the facility in Nigeria over the past year. He emphasized the significance of this new research center, saying, "Our new clinical research facility brings hope to the millions of individuals with sickle cell disease, the warriors who have never been educated on this disease, and the many families who have lost their loved ones. This research center allows them to actively participate in the development of new sickle cell therapies. This is just the beginning; we have a tremendous amount of work remaining."
The opening of Functional Fluidics' new clinical research center and laboratory in Nigeria marks an important step towards improving access to life-changing therapies for those living with sickle cell disease in Sub-Saharan Africa. With their dedication to bridging the gap between clinical research and patient care, Functional Fluidics is making a significant impact on global health.
Filed Under: Business
0 Comments
Latest on Michimich.com
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Critically Acclaimed Crime Drama Trap City, Starring Jeezy and Brandon T. Jackson Hits #1 on STARZ
- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media
- Service Ninjas Debuts First-of-Its-Kind "Membership" Platform for Home Service Pros
- BIYA Forecasts 2025 Surge with ¥300M ($41.8 M USD) in Revenue and ¥25M Profit from Cloud Based HR Solutions: Baiya Intl. Group (N A S D A Q: BIYA)
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- CMR Mechanical Shares 5 Signs Your AC May Be in Desperate Need for Repair
- Michigan SEO Group Shares 5 Proven Ways to Boost Social Media Engagement for Small Businesses
- Mussio Painting Shares The Benefits of Working with Professional Painters in Ann Arbor
- Family Caregivers in Michigan Can Now Get Paid Through Medicaid with Family Aide Home Care
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit